Proposals for the measurement of anti-β2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies [6]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 10, 2004, Pages 1860-1862

  Reber, Guido ^d   Tincani, A ^a   Sanmarco, M ^b   de Moerloose, P ^d   Boffa, M C ^c  

^a Department of Paediatrics   (Italy)

^b HÔPITAL DE LA CONCEPTION   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; POLYCLONAL ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; BINDING AFFINITY; BIOAVAILABILITY; BIOTECHNOLOGICAL PRODUCTION; CALIBRATION; CALIBRATOR; COMMERCIAL PHENOMENA; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; GOOD MANUFACTURING PRACTICE; HEALTH PROMOTION; HUMAN; LETTER; OPTICAL DENSITY; PRIORITY JOURNAL; QUALITY CONTROL; THROMBOSIS; UNIVERSITY;

AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; METHODS; REFERENCE STANDARDS;

EID: 13244292209     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00910.x     Document Type: Letter

References (13)

1. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
2. Galli M, Comfurius P, Maasen C, Hemker HC, de Baets MH, van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
3. Matsuura E, Igarashi Y, Fujimoto K, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177.
4. 2-glycoprotein I antibodies and thrombosis. Clin Rev Allergy Immunol 1995; 13: 67-72.
5. 2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
6. Wilson WA, Gharavi AE, Koike T, Lockshin D, Branch DW, Piette J-C, Brey R, Derksen R, Harris EN, Hughes GRV, Tripplet DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42 1309-11.
7. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-52.
8. Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G, Koike T, Ichikawa K, Meroni P, Boffa MC. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-83.
9. Harris EN. The second international anti-cardiolipin standardization workshop/The Kingston anti-phospholipid antibody (KAPS) Study Group. Am J Clin Pathol 1990; 94: 476-84.
10. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibodies assays. A cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002; 118: 548-57.
11. 2-glycoprotein I measurement. A collaborative study in the frame of the European forum on antiphospholipid antibodies standardization group. Thromb Haemost 2002; 88: 66-73.
12. 2-glycoprotein I antibodies. Arthritis Rheum 1999; 42 2461-70.
13. de Moerloose P, Boehlen F, Reber G, Dechevrens O, Herrmann F, Michel JP. Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up. Age Ageing 1997; 26: 319-20.